TRICORTONE 0.02% CREAM triamcinolone acetonide 0.2mg/g tube オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

tricortone 0.02% cream triamcinolone acetonide 0.2mg/g tube

aspen pharmacare australia pty ltd - triamcinolone acetonide, quantity: 0.2 mg/g - cream - excipient ingredients: emulsifying wax; lactic acid; purified water; isopropyl palmitate; glycerol; benzyl alcohol; sorbitol solution (70 per cent) (non-crystallising) - indications as at 22 october 1998: in the treatment of the following dermatoses: atopic dermatitis, eczematous dermatitis, nummular eczema, contact dermatitis, anal and vulval pruritus, otitis externa, seborrhoeic dermatitis, exzematised psoriasis, neurodermatitis.

DIFFERIN adapalene 1mg/g cream tube オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

differin adapalene 1mg/g cream tube

galderma australia pty ltd - adapalene, quantity: 1 mg/g - cream - excipient ingredients: propyl hydroxybenzoate; carbomer 934p; methyl hydroxybenzoate; cyclomethicone; squalane; sodium hydroxide; purified water; disodium edetate; methyl glucose sesquistearate; phenoxyethanol; peg-20 methyl glucose sesquistearate; glycerol - differin topical cream 0.1% is indicated for the topical treatment of comedo, papular and pustular acne (acne vulgaris) of the face, chest or back.

BACTROBAN mupirocin (as calcium) 20mg/g cream tube オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

bactroban mupirocin (as calcium) 20mg/g cream tube

glaxosmithkline australia pty ltd - mupirocin calcium, quantity: 20.7683 mg/g - cream - excipient ingredients: cetyl alcohol; benzyl alcohol; purified water; cetomacrogol 1000; stearyl alcohol; liquid paraffin; xanthan gum; phenoxyethanol - bactroban (mupirocin) cream is indicated for the topical treatment of secondarily infected traumatic skin lesions such as small lacerations, sutured wounds or abrasions.

EMLA 5% CREAM tube オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

emla 5% cream tube

aspen pharmacare australia pty ltd - lidocaine, quantity: 25 mg/g; prilocaine, quantity: 25 mg/g - cream - excipient ingredients: sodium hydroxide; purified water; ethoxylated hydrogenated castor oil; carbomer 934p - topical anesthesia of the skin prior to insertion of iv catheters, blood sampling, vaccination; superficial surgical procedures, including split skin grafting. topical anaesthesia of leg ulcers to facilitate mechanical cleansing and debridement. topical anaesthesia of genital skin prior to superficial surgical procedures or infiltration anaesthesia. topical anaesthesia of the skin prior to minor superficial cosmetic procedures.

Dithrocream 0.5%w/w アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

dithrocream 0.5%w/w

dermal laboratories ltd - dithranol - cream - 0.5 percent weight/weight - antracen derivatives; dithranol

Dithrocream 0.1%w/w アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

dithrocream 0.1%w/w

dermal laboratories ltd - dithranol - cream - 0.1 percent weight/weight - antracen derivatives; dithranol

Dithrocream 1% w/w アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

dithrocream 1% w/w

dermal laboratories ltd - dithranol - cream - 1.0 percent weight/weight - antracen derivatives; dithranol

Dithrocream 0.25%w/w アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

dithrocream 0.25%w/w

dermal laboratories ltd - dithranol - cream - 0.25 percent weight/weight - antracen derivatives; dithranol

Dithrocream 2% w/w アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

dithrocream 2% w/w

dermal laboratories ltd - dithranol - cream - 2 percent weight/weight - antracen derivatives; dithranol

GAMUNEX normal immunoglobulin (Human) 20g/200mL intravenous solution vial オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

gamunex normal immunoglobulin (human) 20g/200ml intravenous solution vial

grifols australia pty ltd - normal immunoglobulin, quantity: 10 mg/ml - injection - excipient ingredients: glycine; water for injections - replacement therapy in: - primary immunodeficiency (pi) diseases; - symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. immunomodulation in: - idiopathic thrombocytopaenic purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count; - guillain barr? syndrome (gbs); - chronic inflammatory demyelinating polyneuropathy (cidp); - kawasaki disease.